| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $86.7M | +22.9% |
| SG&A Expense | $29.8M | +114.2% |
| Operating Income | -$116.5M | -38.0% |
| Income Tax | -$948K | -95.1% |
| Net Income | -$121.8M | +26.3% |
| EPS (Basic) | -$4.19 | +70.5% |
| EPS (Diluted) | -$4.19 | +70.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $187.6M | +1.2% |
| Current Assets | $296.6M | +9.6% |
| Total Assets | $360.3M | +19.4% |
| Current Liabilities | $26.7M | -53.9% |
| Total Liabilities | $44.0M | -29.3% |
| Stockholders' Equity | $316.3M | +302.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$131.8M | -286.8% |
| Capital Expenditures | $16.1M | +287.8% |
| Investing Cash Flow | -$47.1M | +36.0% |
| Financing Cash Flow | $181.5M | -32.6% |
| Free Cash Flow | -$147.9M | -286.9% |